Proniosomal Gel: Formulation and Charecterization of an Antifungal Drug (Butenafine HCL) Loaded Proniosomes for Topical Delivery

Authors

  • Thimmaraju D R

  • Dr. Abdul Nasir Kurnool

Keywords:

butenafine hydrochloride, fungal infection, proniosomes, slurry method, in-vitro diffusion studies, antifungal activity

Abstract

The present proniosomal gel investigation was aimed to minimize the adverse effects associated with present topical butenafine hydrochloride formulations and made to enhance its bioavailability and sustained release by novel proniosomal drug delivery system. Butenafine hydrochloride is an allylamine class of advanced antifungal drug. Which mainly recommended to treat long term topical fungal infection. Proniosomes were prepared by slurry method using different concentrations of non-ionic surfactant (span and tween) and evaluated various parameter like surface morphology, entrapment efficiency, drug content, viscosity, drug content, in-vitro % drug release, in-vitro fungal activity and stability studies. The results showed that formulation (F3) containing span 60: cholesterol (1:2) showed highest drug content (99.13%) and entrapment efficiency (79.87%) compared to other formulations. The pH and viscosity of prepared all proniosomal gel formulation were found in range (5.40-6.11) and (8920-14400CPs) correspondingly.

How to Cite

Proniosomal Gel: Formulation and Charecterization of an Antifungal Drug (Butenafine HCL) Loaded Proniosomes for Topical Delivery. (2020). Global Journal of Medical Research, 20(41), 35-46. https://medicalresearchjournal.org/index.php/GJMR/article/view/2166

References

K. Kumar, A. Rai (2011) Development and evaluation of proniosomes as a promising drug carrier to improve transdermal drug delivery International Research Journal of Pharmacy. 2(11), 71-74.

Shitalamin Poojary (2017) Topical antifungals: A review and their role in current management of dermatophytoses Clinical Dermatology Review. 1(3), 24. https://doi.org/10.4103/cdr.cdr_34_17

Mathur V, Satrawala Y, Rajput MS (2014) Physical and chemical penetration enhancers in transdermal drug delivery system. 4(3).

P. Lam, K. Lee, R. Wong, G. Cheng, Z. Bian, C. Chui, R. Gambari (2018) Recent advances on topical antimicrobials for skin and soft tissue infections and their safety concerns Critical reviews in microbiology. 44(1), 40-78. https://doi.org/10.1080/1040841x.2017.1313811

Verma S, Utreja P (2019) Vesicular nanocarrier based treatment of skin fungal infections: Potential and emerging trends in nanoscale pharmacotherapy Asian Journal of Pharmaceutical Sciences. 14(2), 117-129.

Kaur IP, Kakkar S (2010) Topical delivery of antifungal agents Expert opinion on drug delivery. 7(11), 1303-1327.

Monica Rao, Priyanka Kamble (2018) Formulation and evaluation of antifungal proniosomal gel for oral candidiasis Journal of Drug Delivery and Therapeutics. 8(4), 291-301. https://doi.org/10.22270/jddt.v8i4.1793

Shitalamin Poojary (2017) Poojary SA. Topical antifungals: A review and their role in current management of dermatophytoses. 1(3), 24. https://doi.org/10.4103/cdr.cdr_34_17

Kumar GP, Rajeshwarrao P (2011) Nonionic surfactant vesicular systems for effective drug delivery-an overview Acta pharmaceuticasinica B. 1(4), 208-219.

Open base Open chemistry data base ncbi. https://pubchem.ncbi.nlm.nih.gov/compound/2484

A. Gupta (2002) Butenafine: an update of its use in superficial mycoses Skin Therapy Lett. 7(7), 1-2.

Bomma G, Harika SM, Babu AM, Bakshi V (2017) Formulation Development and Evaluation of Proniosomal Powder of Candesartan Analytical Chemistry Letters. 7(4), 567-577.

Abdou EM, Ahmed NM (2016) Terconazole proniosomal gels: effect of different formulation factors, physicochemical and microbiological evaluation. 5(1).

P. Salve (2011) Development and evaluation of topical drug delivery system for terbinafine hydrochloride using niosomes Research Journal of Topical and Cosmetic Sciences. 2(2), 52-63.

Gurrapu A, Jukanti R, Bobbala SR, Kanuganti S, Jeevana JB (2012) Improved oral delivery of valsartan from maltodextrin based proniosome powders Advanced Powder Technology. 23(5), 583-590.

Shilakari G, Asthana A, Singh D, Sharma PK (2016) Etodolac containing topical niosomal gel: formulation development and evaluation. 2016.

S. Desai, A. Doke, J. Disouza, R. Athawale (2011) Development and evaluation of antifungal topical niosomal gel formulation Int J Pharm Pharm Sci. 3(5), 224-231.

Balch DA, Cooke RA (1970) A study of the composition of hen's egg-shell membranes InAnnales de Biologie Animale Biochimie Biophysique 1970 (Vol 10, No. 2, 13-25.

Hanan El-Laithy, Omar Shoukry, Laila Mahran (2011) Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies European journal of pharmaceutics and biopharmaceutics. 77(1), 43-55. https://doi.org/10.1016/j.ejpb.2010.10.011

T. Yoshioka, B. Sternberg, A. Florence (1994) Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitantriester (Span 85) Int J Pharm. 105, 1-6.

Proniosomal Gel: Formulation and Charecterization of an Antifungal Drug (Butenafine HCL) Loaded Proniosomes for Topical Delivery

Published

2020-07-06

How to Cite

Proniosomal Gel: Formulation and Charecterization of an Antifungal Drug (Butenafine HCL) Loaded Proniosomes for Topical Delivery. (2020). Global Journal of Medical Research, 20(41), 35-46. https://medicalresearchjournal.org/index.php/GJMR/article/view/2166